NHS to cut the red tape to support 50K NHS postgraduate doctors
New measures are part of NHS' broader efforts to retain its skilled workforce and ensure high-quality patient careÂ
In a significant move to enhance the...
England to roll out first targeted treatment for childhood brain tumours ‘gliomas’
The treatment has been found to slow the progression of gliomas by over threefold compared to standard chemotherapyÂ
After receiving approval from the National Institute...
Patients experience lower mortality rates when treated by female doctors, study reveals
Women are more likely to benefit from receiving treatment from female doctors than men
If you believe you'll feel better under the care of...
Mundipharma empowers global healthcare access with acquisition of Rezafungin rights
The acquisition by Mundipharma aims to intensifying focus on infectious diseases
In a recent announcement, Mundipharma, a leading global pharmaceutical company, has announced its acquisition...
Breast Cancer survivors face heightened risk of second cancers, new research reveals
Higher risks of breast cancer and second primary cancers for individuals residing in areas of greater socioeconomic deprivationÂ
A groundbreaking study analysing data from nearly...
Have NHS ambulance response times improved? Lib Dems raise concern
The party sounds alarm over ambulance Category 2 delays encompassing urgent stroke and heart attack cases
The NHS's latest report on ambulance services in England...
Sigma Pharmaceuticals donates £20K to local charity Citizen Advice Watford
Sigma will continue to partner with the local charity throughout the year Â
Sigma Pharmaceuticals, a leading pharmacy wholesaler and distributor in the UK, has once...
1 in 3 ethnic minorities need 3 or more GP visits for cancer diagnosis, new survey reveals
Currently, only 60 per cent of cancer diagnoses are taking place before the cancer has progressed
The latest findings from the National Cancer Patient Experience...
Pharmacists’ role in Fit Note Certification sees modest uptake, NHS data reveals
A total of 1.4 per cent of the fit note seekers relied on pharmacists to issue them the certification
Recent NHS data sheds light on...
Aspire expands oncology portfolio with prostate cancer hormone therapy
One man dies from prostate cancer every 45 minutes in the UKÂ
Aspire Pharma Limited has solidified its position as a leading specialty generics enterprise...
Current Issue March 2024
